Clinical trials: Chin Retrusion
Chin Augmentation and Correction
New Dermal Filler for Chin Correction and Augmentation
Randomized, evaluator-blinded, no treatment controlled multicenter study to evaluate safety and effectiveness of GP0109 for augmentation and correction or retrusion in the chin region in Canada
- Trial name
- NCT04631263
- Testing
- Hyaluronic Acid
- Where
- 9 sites in Canada
- Volunteers
- 140 people, healthy volunteers welcome
- Sponsor
- Galderma R&D
Aging, Chin Retrusion
Safety and Effectiveness Evaluation of TEOSYAL® TPVM Versus COMPARATOR for the Remodeling of the Lower Face
The clinical study is designed to prospectively evaluate the safety and effectiveness of TEOSYAL® TPVM when compared to COMPARATOR for the remodeling of the lower face
- Trial name
- LIFTUP (NCT05986630)
- Testing
- TEOSYAL® TPVM, COMPARATOR
- Where
- Switzerland
- Volunteers
- 155 people, healthy volunteers welcome
- Sponsor
- Teoxane SA
Chin Retrusion
Restylane Shaype Versus Juvederm Volux for Chin Augmentation
This study aims to compare two injectable products (Restylane Shaype and Juvéderm Volux) for aesthetic augmentation of the chin
- Trial name
- NCT06336772
- Testing
- Restylane Shaype, Juvéderm Volux
- Where
- Canada
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Erevna Innovations Inc.
Chin Augmentation, Chin Retrusion
Safety and Effectiveness of Restylane Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin Profile
The primary objective of the study was to demonstrate non-inferiority of Restylane Lyft with Lidocaine versus a comparator-control for augmentation of the chin region to improve the chin profile.
- Trial name
- NCT05777759
- Testing
- Restylane Lyft with Lidocaine, Juvederm Voluma XC
- Where
- 12 sites in United States, Puerto Rico
- Volunteers
- 175 people, healthy volunteers welcome
- Sponsor
- Galderma R&D
Chin Retrusion, Chin Augmentation
A Study to Evaluate the Safety and Efficacy of Restylane Defyne for Chin Augmentation and Correction of Chin Retrusion
To demonstrate the effectiveness of Restylane Defyne for chin augmentation and correction of chin retrusion by demonstrating the superiority in responder rates relative to no treatment.
- Trial name
- NCT03624816
- Testing
- Restylane Defyne
- Where
- 11 sites in United States
- Volunteers
- 140 people, healthy volunteers welcome
- Sponsor
- Galderma R&D